China is witnessing a rapid spread of human metapneumovirus (HMPV), a respiratory virus causing flu-like symptoms. This outbreak has drawn comparisons to the early stages of the COVID-19 pandemic due to its swift transmission and the strain it is placing on healthcare systems.
Reports on social media claim that hospitals and crematories are under pressure, with other respiratory illnesses like influenza A, Mycoplasma pneumoniae, and COVID-19 circulating simultaneously. However, no official emergency declaration has been made.
To address the situation, the National Disease Control and Prevention Administration has launched a monitoring system to track unexplained pneumonia cases, aiming to enhance readiness for future outbreaks and manage unknown pathogens more effectively.
HMPV symptoms resemble those of the flu, including fever, cough, nasal congestion, and shortness of breath. Severe cases may progress to bronchitis or pneumonia. The virus spreads via respiratory droplets, close contact, and contaminated surfaces.
Preventive measures include regular handwashing, avoiding face-touching, and staying away from those exhibiting symptoms. Young children, older adults, and individuals with weakened immune systems are at higher risk.
Currently, no specific treatment or vaccine exists for HMPV. Care focuses on symptom management and preventing complications. Studies suggest a rise in HMPV cases after COVID-19 restrictions were lifted, as reduced virus exposure weakened immunity.
Get the latest international news and global stories wherever you prefer.
Add ProPakistani to Preferred Sources and see more of our stories in Google Search and Top Stories.